Thorne FloraMend Prime Probiotic review: three strains, one shared total

Identify the thirty-capsule product

The current US page identifies SKU SF811 and displays $56 for 30 capsules. The panel defines one capsule as a serving and lists a proprietary blend of Lactobacillus gasseri KS-13, Bifidobacterium longum MM-2 and Bifidobacterium bifidum G9-1. Individual strain quantities are not provided.

That is different from simply listing three species without their strain codes. The codes help a reader compare a label with a research report. They still leave questions about the proportion of each organism and whether the tested preparation matches the bottle being considered. Our strain-and-unit guide explains why those details belong together.

Keep the exact name in a product list. FloraMend Prime Probiotic is not FiberMend, which is a different Thorne product, and it is not another probiotic in the same catalog. A similar brand presentation does not make ingredient panels or study references interchangeable.

Read the potency and capsule details together

The label image states five billion live cells per capsule at expiration. The website's ingredient table expresses the total as five billion CFUs. Neither source divides that total equally among the three strains. We have preserved the total instead of inventing an individual count or converting it into milligrams.

The pictured delayed-release capsule includes hydroxypropyl methylcellulose, pectin and water; potato starch and silica are also listed. Pectin in that shell is not a quantified daily fiber serving. The image provides more detail about the capsule than the shorter website ingredient list, which is why both records matter.

Thorne cautions against removing the powder because the capsule is part of its intended delivery mechanism. If swallowing it is difficult, ask a pharmacist or clinician about a suitable alternative rather than opening it based on a general probiotic tip. This is a product-specific handling question, not an invitation to devise another route of use.

A research match needs the right outcome

A 2017 randomized, double-blind trial studied these three named strains in 173 people with self-reported seasonal allergies. Participants received two capsules totaling three billion CFUs daily or placebo for eight weeks. Their average age was about 27, and the main question concerned allergy-related quality of life.

The reported questionnaire improvement favored the probiotic group, while measured changes in total IgE and regulatory T-cell percentage did not differ between groups. This account comes from the trial abstract. It is not a study of today's five-billion capsule in older GLP-1 medicine users, and it does not establish prevention of medication-related nausea or constipation.

The product page also promotes weight-management benefits. We did not establish a matching finished-product trial supporting that claim in the population this site discusses. A reported ingredient study, a strain name and an online customer rating answer different questions. The page's AI-generated customer-review summary is not clinical evidence and was not used to predict results.

Storage is a practical instruction, not a durability test

The pictured bottle directs cool, dry storage with the container tightly sealed and says refrigeration is not required. That is useful when comparing routines with products whose labels call for refrigeration. It does not specify a safe interval in a hot vehicle or prove the condition of an individual delivery.

If a shipment arrives with a broken seal or questionable handling, keep the lot and expiration details and ask the seller or manufacturer for guidance. A capsule's appearance cannot demonstrate how many viable organisms remain. The storage and travel note explains how to keep a delivery question specific.

Do not treat another brand's shelf-life statement as an answer for this one. The guarantee printed on a label depends on the product and its handling conditions. Our testing-claims guide separates a manufacturer's potency statement from an independently inspected report for a particular batch.

Consider suitability before the purchase

NCCIH notes that probiotic risks can be greater in people who are seriously ill or have weakened immune systems. A general product statement that interactions are not known does not establish compatibility with every person's medicines, conditions or care setting. Bring the full supplement label to the responsible clinician when those issues apply.

The manufacturer warns against use with a history of hypersensitivity to its ingredients and advises pregnant users to consult a healthcare practitioner. The serious-illness guide covers why broad immune-support language should not be read as individual clearance.

For persistent or concerning digestive symptoms during prescribed treatment, contact the care team following the medication guide. A new supplement can add another variable to an already difficult discussion. The digestive-symptom note helps organize the timing and product list without selecting treatment or changing a prescription.

Compare the offer without promising a result

At the displayed $56 bottle price, thirty labeled servings work out to about $1.87 each before shipping, tax or discounts. The page advertises subscription savings up to 20%; we did not establish which tier or renewal conditions a particular shopper would receive. Keep that conditional promotion separate from the one-time displayed amount.

CoreAge Rx GLP-1 Support is a different blend with its own public-information limits. Read the CoreAge review and seven-product comparison with the commercial first position visible. No ordering of products here demonstrates comparative clinical benefit.

The strongest reason to consider this review useful is its clear identification of what is known: the strain codes, shared total, expiration statement and capsule design. The unresolved question is whether this exact product serves a worthwhile purpose in your care. Use the question list to ask that question before turning a readable label into an assumed recommendation.